Zhejiang Shengda Bio-Pharm Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 373.926 million compared to CNY 354.627 million a year ago. Operating income was CNY 49.838 million compared to CNY 61.499 million a year ago. Net income was CNY 44.653 million compared to CNY 51.712 million a year ago. Basic earnings per share from continuing operations was CNY 0.4 compared to CNY 0.46 a year ago.